Expert: High-affinity ligand for synaptic vesicle protein 2A (SV2A), modulating neurotransmitter release and exhibiting antiepileptic activity through a novel mechanism.
Everyday: Binds to a protein in brain cells that helps control the release of brain chemicals, reducing seizures.
Levetiracetam, a first-line anticonvulsant targeting SV2A for partial-onset and generalized seizures. Widely used due to minimal drug interactions and broad efficacy; available in IV, oral, and extended-release formulations.